Search

Search Constraints

You searched for: Author/Creator Laskin, Janessa

Search Results

1. A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226. (May 2020)

3. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial. Issue 5 (May 2016)

6. ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent. (29th June 2015)

7. Clinical and cost outcomes following genomics‐informed treatment for advanced cancers. (21st June 2021)

8. Diagnostic Value of Next-Generation Sequencing in an Unusual Sphenoid Tumor. (7th May 2014)

9. Diagnostic Value of Next‐Generation Sequencing in an Unusual Sphenoid Tumor. (7th May 2014)

10. Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum‐pemetrexed for T790M mutation‐positive advanced non–small cell lung cancer. Issue 2 (26th November 2019)